Styrene

Styrene

SCHEMBL2981589

C1CO1.C1CO1.C=Cc1ccccc1

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.74
TSHR P16473 1/20 0.74
LMNA P02545 4/20 0.39
TDP1 Q9NUW8 2/20 0.39
TP53 P04637 1/20 0.39
CRHBP P24387 2/20 0.39
CRHR2 Q13324 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HTT P42858 1/20 0.39
MAOB P27338 1/20 0.38
CYP2A6 P11509 1/20 0.38
HDAC8 Q9BY41 2/20 0.37
RAB9A P51151 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
KDM4E B2RXH2 1/20 0.36
AGTR1 P30556 1/20 0.36
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Styrene SCHEMBL547979 1.00 ALDH1A1 (0.74) ALDH1A1TSHRLMNATDP1TP53
Styrene SCHEMBL28085068 1.00 ALDH1A1 (0.74) ALDH1A1TSHRLMNATDP1TP53
Styrene SCHEMBL11586814 0.97 ALDH1A1 (0.70) ALDH1A1TSHRLMNATDP1TP53
Styrene SCHEMBL27490580 0.97 ALDH1A1 (0.70) ALDH1A1TSHRLMNATDP1TP53
Styrene SCHEMBL7528295 0.95 ALDH1A1 (0.67) ALDH1A1TSHRLMNATDP1TP53
Styrene SCHEMBL11673319 0.92 ALDH1A1 (0.70) ALDH1A1TSHRLMNATDP1TP53
Styrene SCHEMBL27801477 0.89 ALDH1A1 (0.58) ALDH1A1TSHRLMNATDP1MAOB
Styrene SCHEMBL18343102 0.89 ALDH1A1 (0.93) ALDH1A1TSHRLMNATDP1TP53
Styrene SCHEMBL4282088 0.89 ALDH1A1 (0.93) ALDH1A1TSHRLMNATDP1TP53
Styrene SCHEMBL1944454 0.89 ALDH1A1 (0.93) ALDH1A1TSHRLMNATDP1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100172861-A1 Anionic Polymers as Toxin Binders and Antibacterial Agents GENZYME CORPORATION (US) 2010-07-08 US disclosed
US-7723412-B2 Stabilization of thermoplastic nanocomposites CIBA SPECIALTY CHEMICALS CORPORATION (US) 2010-05-25 US disclosed
US-7678369-B2 Anionic polymers as toxin binders and antibacterial agents GENZYME CORPORATION (US) 2010-03-16 US disclosed
EP-1824919-B1 STABILIZED ORGANIC MATERIALS CONTAINING FILLERS BASF SE (DE) 2009-12-09 EP disclosed
US-20090298978-A1 Stabilized organic materials containing fillers CIBA SPECIALTY CHEMICALS CORP. 2009-12-03 US disclosed
EP-1592741-B1 STABILIZATION OF THERMOPLASTIC NANOCOMPOSITES CIBA HOLDING INC (CH) 2009-01-14 EP disclosed
US-20080194743-A1 processing stabilizer selected from the group consisting of hydroxylamine stabilizers, and an antistatic agent selected from an ethoxylated amine and/or an ethoxylated amide, as stabilizers for protecting organic materials ROTZINGER BRUNO 2008-08-14 US disclosed
US-7375149-B2 Stabilization of organic materials CIBA SPECIALTY CHEMICALS CORP. (US) 2008-05-20 US disclosed
EP-1824919-A1 STABILIZED ORGANIC MATERIALS CONTAINING FILLERS CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) 2007-08-29 EP disclosed
EP-1189622-B1 ANIONIC POLYMERS AS TOXIN BINDERS AND ANTIBACTERIAL AGENTS GENZYME CORP (US) 2007-07-25 EP disclosed
EP-1149133-B1 SYNTHETIC POLYMERS COMPRISING ADDITIVE BLENDS WITH ENHANCED EFFECT CIBA SC HOLDING AG (CH) 2004-03-17 EP disclosed
US-20030138397-A1 Anionic polymers as toxin binders and antibacterial agents GELTEX PHARMACEUTICALS, INC. 2003-07-24 US disclosed
US-6517827-B1 Polystyrene sulfonate polymer; Clostridium difficile GELTEX PHARMACEUTICALS, INC. 2003-02-11 US disclosed
US-6517826-B1 Polystyrene sulfonate polymer; Clostridium difficile GELTEX PHARMACEUTICALS, INC. 2003-02-11 US disclosed
EP-1189622-A2 ANIONIC POLYMERS AS TOXIN BINDERS AND ANTIBACTERIAL AGENTS Geltex Pharmaceuticals, Inc. (US) 2002-03-27 EP disclosed
US-6290946-B1 ADMINISTERING TO THE ANIMAL A THERAPEUTICALLY EFFECTIVE AMOUNT OF A POLYMER HAVING A PLURALITY OF PENDANT ACID FUNCTIONAL GROUPS WHICH ARE DIRECTLY ATTACHED TO THE POLYMER BACKBONE OR ATTACHED TO THE POLYMER BACKBONE BY A SPACER GROUP. GELTEX PHARMACEUTICALS, INC. 2001-09-18 US disclosed
WO-2000069428-A2 ANIONIC POLYMERS AS TOXIN BINDERS AND ANTIBACTERIAL AGENTS GELTEX PHARMACEUTICALS, INC. (US) 2000-11-23 WO disclosed
EP-0463400-B1 Transparencies XEROX CORP (US) 1997-04-02 EP disclosed
US-5202205-A TRANSPARENCIES COMPRISING METAL HALIDE OR UREA ANTISTATIC LAYER XEROX CORPORATION (US) 1993-04-13 US disclosed
EP-0463400-A1 Transparencies XEROX CORPORATION (US) 1992-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100172861-A1 Anionic Polymers as Toxin Binders and Antibacterial Agents MSN, ANTXR2, PNKP ALDH1A1 4470/4885TSHR 1345/4885LMNA 2848/4885
US-20030138397-A1 Anionic polymers as toxin binders and antibacterial agents MSN, ANTXR2, PNKP ALDH1A1 4470/4885TSHR 1345/4885LMNA 2848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.